Facetten
Zugriff
Einrichtung
Medientyp
- Text 4
Karte
Erscheinungsjahr
Autor/in
- Blauvelt, Andrew
- Papp, Kim A
- Armstrong, April 2
- Augustin, Matthias 2
- Gordon, Kenneth B 2
- alle zeigen
Sprache
- Englisch 4
4 Einträge gefunden
-
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
- Reich, Kristian
- Papp, Kim A
- Blauvelt, Andrew
- Langley, Richard G
- Armstrong, April
- Warren, Richard B
- Gordon, Kenneth B
-
Bimekizumab versus Adalimumab in Plaque Psoriasis
- Warren, Richard B
- Blauvelt, Andrew
- Bagel, Jerry
- Papp, Kim A
- Yamauchi, Paul
- Armstrong, April
- Langley, Richard G
-
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- Gordon, Kenneth B
- Strober, Bruce
- Lebwohl, Mark
- Augustin, Matthias
- Blauvelt, Andrew
- Poulin, Yves
- Papp, Kim A
-
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders. A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
- Blauvelt, Andrew
- Papp, Kim A
- Griffiths, Christopher E M
- Puig, Luis
- Weisman, Jamie
- Dutronc, Yves
- Kerr, Lisa Farmer